Listen up, folks: We’ve got these brain tumors, called Lower-grade gliomas (LGGs), and they’re tricky. They blend in, making it tough for doctors to spot the bad stuff. Now, 5-ALA, that’s a technique they’ve been using, but let me tell you, it’s not cutting it for LGGs. So, what did we do? We came up with something huge – a new PET/NIR probe that targets these tumors like a missile. It’s going to change the game.

Here’s the deal: We ran a trial, not just any trial, but a top-notch, single-center trial. We had two groups of patients, and we were all about that precision. Group 1 got the VIP treatment with our new probe before and during surgery. Group 2, they just got the intraoperative glow. We were looking for two things: does our PET scan predict the glow, and how good is the glow at finding the bad tissue?

The results – and they’re terrific, believe me: Out of 39 patients, 25 were lighting up like Christmas trees, and 14, not so much. But here’s the kicker: our PET scan was spot on, 100% accurate in predicting who would glow. MRI? Not so much, only 87.2%. We took 125 samples, and our glow was right on the money, especially for the really bad stuff, with both sensitivity and specificity around 88%. For the not-so-bad stuff, still better than a coin flip.

So, what’s the bottom line? This new probe we’ve got is a winner. It’s going to make surgeries for LGGs great again. It’s better than 5-ALA, and it’s going to help doctors see exactly where to cut. We’re talking about better planning, better surgery, and better outcomes. It’s going to be huge.